1. Home
  2. MEG vs ARCT Comparison

MEG vs ARCT Comparison

Compare MEG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$25.10

Market Cap

943.9M

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$6.87

Market Cap

194.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
ARCT
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
943.9M
194.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MEG
ARCT
Price
$25.10
$6.87
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$33.50
$38.44
AVG Volume (30 Days)
313.8K
627.7K
Earning Date
02-25-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$826,323,000.00
$97,601,000.00
Revenue This Year
$19.70
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.77
N/A
52 Week Low
$10.51
$5.85
52 Week High
$32.00
$24.17

Technical Indicators

Market Signals
Indicator
MEG
ARCT
Relative Strength Index (RSI) 43.75 47.68
Support Level $24.21 $6.02
Resistance Level $26.11 $6.75
Average True Range (ATR) 0.90 0.30
MACD -0.08 0.16
Stochastic Oscillator 33.14 69.87

Price Performance

Historical Comparison
MEG
ARCT

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: